Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube

  • Contaminated with Staphylococcus aureus.
  • Company: Pharmacal
  • Drugs
  • FDA
  • May 8, 2026

Product details

  • Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube

Company announcement

Pharmacal is recalling one lot of MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube due to contamination with Staphylococcus aureus.

The product was distributed nationwide to wholesale, retail (HE BUTT Grocery), and internet distributors (Amazon).

The affected lot is 1024088 with an expiration date of November 2026.

Risk:

Use of the product could result in a range of infections from localized to severe or life-threatening adverse events. Patients with weakened immune systems or compromised skin — such as those with wounds, burns, or skin disorders — are at increased risk for serious infections, including skin and skin structure infections, infective endocarditis (infection of the heart valves), bone and joint infections, bloodstream infections, and life-threatening conditions like sepsis and septic shock. To date, Pharmacal has not received any reports of adverse events related to this recall.

Impacted states: Nationwide

Products:

- MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, 6oz tube (UPC code(s): 012277051067)

Contact

For more information, call 800-558-6614 or email aimho@pharmacalway.com.

View the original FDA notice

Browse all recalls

Related recalls